10x Genomics Total Assets 2018-2024 | TXG

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

10x Genomics total assets from 2018 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

10x Genomics total assets from 2018 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$37.2B
Tempus AI (TEM)	$7.9B
Hims & Hers Health (HIMS)	$6.5B
Inspire Medical Systems (INSP)	$5.7B
IRhythm Technologies (IRTC)	$3.5B
Privia Health (PRVA)	$2.7B
Enovis (ENOV)	$2.6B
Azenta (AZTA)	$2.5B
Clover Health Investments (CLOV)	$2.2B
Omnicell (OMCL)	$2B
Schrodinger (SDGR)	$1.8B
Phreesia (PHR)	$1.6B
Butterfly Network (BFLY)	$837M
Standard BioTools (LAB)	$681M
Talkspace (TALK)	$534M
Fulgent Genetics (FLGT)	$519M
TruBridge (TBRG)	$342M
Health Catalyst (HCAT)	$341M
SOPHiA GENETICS SA (SOPH)	$241M
Pulmonx (LUNG)	$239M
American Well (AMWL)	$158M
EUDA Health Holdings (EUDA)	$92M
P3 Health Partners (PIII)	$70M
HeartBeam (BEAT)	$57M
CareCloud (CCLD)	$55M
Zepp Health (ZEPP)	$45M
SHL Telemedicine (SHLT)	$42M
Outset Medical (OM)	$41M
111 (YI)	$38M
Zhongchao (ZCMD)	$34M